Dr Vincenzo Teneggi
is the Senior Medical Director at D3, A*STAR, Singapore. He has served in a number of positions of increasing responsibility as Clinical Medical Expert, Head of Drug Surveillance Service, Head of Phase II-IV Clinical Research, Clinical Pharmacology Expert in Translational Medicine, Director of Early Clinical Drug Discovery for Drug Dependency, Director of Early Clinical Drug Discovery for Schizophrenia and Bipolar Disorders, Head of Early Development & Clinical Pharmacology for Asia Pacific. Duties were accomplished within several international pharmaceutical companies like Wellcome, Glaxo-Wellcome, GSK, Novartis and Roche.
Dr Teneggi has an extensive knowledge on late and early clinical phase development, multiple therapeutic areas, clinical drug safety and clinical pharmacology, biomarker strategy implementation from phase 1 to proof of concept studies and drug profiling. He received his medical degree at the University of Rome “La Sapienza”, where he also specialised in Lung Diseases and Internal Medicine. Dr Teneggi has published scientific papers in major journals and made communications in conferences in the field of cardiovascular, lung, smoking addiction, CNS, as well as early clinical biomarker implementation. He is co-author of book chapters and patent invention in the same fields.